Awakn Life Sciences Corp. (OTCPK: AWKN.F)
Health Care · Biotechnology · CA
$—
— today · — 1Y
Awakn Life Sciences Corp. (OTCPK: AWKN.F) operates in the Biotechnology industry within the Health Care sector.
Tweenvest scores Awakn Life Sciences Corp. across four factors: quality 15/100. Its strongest factor is quality.
AWKN.F price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- —
- Revenue (TTM)
- $41.02K
- P/E
- —
- EPS
- -0.06
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- $—
- 52-week low
- $—
- Avg volume (3M)
- —
- Shares outstanding
- —
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $468.22B | $264.52 | -0.17% |
| Amgen Inc.NasdaqGS: AMGN | $237.52B | $443.82 | +1.02% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.18B | $146.72 | +0.41% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.91B | $547.58 | -0.09% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.28B | $834.55 | +0.06% |
| argenx SEENXTBR: ARGX | $65.85B | €864.20 | -4.19% |
| Moderna, Inc.NasdaqGS: MRNA | $57.92B | $138.78 | -4.34% |
| CSL LimitedASX: CSL | $57.77B | AU$168.30 | -1.69% |
Figures last refreshed Aug 18, 2026.